Tyrosine Kinase Inhibitors in EGFR-Mutated Large-Cell Neuroendocrine Carcinoma of the Lung A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-07 ,pp. : 478-483

Karger

Access to resources Recommend Favorite

High Efficacy of First-Line Gefitinib in Non-Asian Patients with EGFR-Mutated Lung Adenocarcinoma

By  

Oncology Research and Treatment, Vol. 33, Iss. 5, 2010-04 ,pp. : 231-238

Karger

Access to resources Recommend Favorite

Near Total Regression of Diffuse Brain Metastases in Adenocarcinoma of the Lung with an EGFR Exon 19 Mutation: A Case Report and Review of the Literature

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-09 ,pp. : 445-451

Karger

Access to resources Recommend Favorite

Achievement of Cure with Gefitinib in Advanced Lung Adenocarcinoma Harboring an Activating EGFR Mutation: A Case Report

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-10 ,pp. : 565-567

Karger

Access to resources Recommend Favorite

CBDCA + Pemetrexed + Bevacizumab and Its Maintenance Chemotherapy in a Case of Solitary Breast Metastasis from a Lung Adenocarcinoma Resistant to Gefitinib

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-10 ,pp. : 546-553

Karger

Access to resources Recommend Favorite